Related Experiment Video
Updated: Mar 26, 2026
08:05
Design and Analysis for Fall Detection System Simplification
Published on: April 6, 2020
11.3K
Etiologic factors in falls from height in pediatric cases
S Kocak1, Z D Dundar2, K Yavuz1
1Emergency Department, Selcuk University Meram Faculty of Medicine, Konya, Turkey.
Summary
Pediatric falls from height, often from balconies, are a significant concern, particularly for unsupervised preschoolers. Enhanced family education and improved building safety regulations are crucial for prevention.
Area of Science:
- Pediatrics
- Public Health
- Injury Prevention
Background:
- Falls from height are a leading cause of accidental injury in children.
- Understanding the specific circumstances and risk factors is essential for developing effective prevention strategies.
Purpose of the Study:
- To investigate the factors contributing to pediatric falls from height.
- To identify precautions for preventing such falls.
Main Methods:
- Prospective study conducted from June 2009 to June 2010.
- Included pediatric patients (<18 years) admitted for accidental falls from at least one meter height.
- Collected data on demographics, fall characteristics, and clinical features.
Main Results:
- 133 pediatric patients were evaluated; 54.1% were male, median age 4 years.
- Balconies were the most common fall site (38%); falls occurred more in spring/summer.
- Head trauma (63%) was the most frequent injury; 55% of young children (0-6 years) were unsupervised.
Conclusions:
- Pediatric falls from height disproportionately affect preschool-aged children.
- Falls are frequently from balconies and occur when children are unsupervised.
- Recommendations include enhanced family education and stricter child safety regulations for building designs (doors, windows, balconies).
More Related Videos
Related Concept Videos
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
460
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
460
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
328
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
328
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
370
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
370
01:24Drug Toxicity: Risk factors
167
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
167
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
697
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
697
01:29Drug Dosing: Infants and Children
733
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
733